IDH1 and neoplasm: Analysis of our conventional chondrosarcomas (CHS) resulted in 56 of 98 samples not being predicted to a methylation class, which was partly accounted for by the DKFZ Classifier providing four different classes for these tumours based on IDH1/2 mutational status.